Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Lees

Showing results (31-40 of 406) with videos related to

Pageof 41
Sort By:
Neurology|May 9, 2007
Clinical heterogeneity of ATP13A2 linked disease (Kufor-Rakeb) justifies a PARK designationAndrew J Lees, Andrew B Singleton
The Lancet. Neurology|April 17, 2007
Pathological gambling in Parkinson's diseaseSean S O'Sullivan, Andrew J Lees
Journal of the Neurological Sciences|February 17, 2018
Endemic atypical parkinsonismLaura Silveira-Moriyama, Andrew J Lees
Movement Disorders Clinical Practice|October 15, 2025
Beyond Pathology: α-Synuclein Homeostasis and Three Principles to Guide ResearchAlberto J Espay, Andrew J Lees
Arquivos De Neuro-Psiquiatria|April 19, 2012
Tricks of the tradeLaura Silveira-Moriyama, Andrew J Lees
Nature Reviews. Neurology|December 17, 2014
Parkinson disease: How reliable are prodromal indicators of Parkinson disease?Laura Silveira-Moriyama, Andrew J Lees
Practical Neurology|September 6, 2013
Neurology and detective writingPeter A Kempster, Andrew J Lees
JAMA Neurology|August 5, 2024
Limitations of the α-Synuclein Seed Amplification Assay in Clinical Practice: Understanding the Pathological Diversity of Parkinson SyndromeHuw R Morris, Andrew J Lees
Journal of Parkinson'S Disease|September 18, 2025
'Pathology is disease' Parkinson's mythology: The 'brain-first-body-first' case studyAlberto J Espay, Andrew J Lees
Brain : a Journal of Neurology|January 8, 2024
Are we entering the 'Tau-lemaic' era of Parkinson's disease?Alberto J Espay, Andrew J Lees
Pageof 41

Showing results (31-40 of 406) with videos related to

Sort By:
Pageof 41
Neurology|May 9, 2007
Clinical heterogeneity of ATP13A2 linked disease (Kufor-Rakeb) justifies a PARK designationAndrew J Lees, Andrew B Singleton
The Lancet. Neurology|April 17, 2007
Pathological gambling in Parkinson's diseaseSean S O'Sullivan, Andrew J Lees
Journal of the Neurological Sciences|February 17, 2018
Endemic atypical parkinsonismLaura Silveira-Moriyama, Andrew J Lees
Movement Disorders Clinical Practice|October 15, 2025
Beyond Pathology: α-Synuclein Homeostasis and Three Principles to Guide ResearchAlberto J Espay, Andrew J Lees
Arquivos De Neuro-Psiquiatria|April 19, 2012
Tricks of the tradeLaura Silveira-Moriyama, Andrew J Lees
Nature Reviews. Neurology|December 17, 2014
Parkinson disease: How reliable are prodromal indicators of Parkinson disease?Laura Silveira-Moriyama, Andrew J Lees
Practical Neurology|September 6, 2013
Neurology and detective writingPeter A Kempster, Andrew J Lees
JAMA Neurology|August 5, 2024
Limitations of the α-Synuclein Seed Amplification Assay in Clinical Practice: Understanding the Pathological Diversity of Parkinson SyndromeHuw R Morris, Andrew J Lees
Journal of Parkinson'S Disease|September 18, 2025
'Pathology is disease' Parkinson's mythology: The 'brain-first-body-first' case studyAlberto J Espay, Andrew J Lees
Brain : a Journal of Neurology|January 8, 2024
Are we entering the 'Tau-lemaic' era of Parkinson's disease?Alberto J Espay, Andrew J Lees
Pageof 41